| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-10 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |